Viral clearance

You have access
Proceedings of the 2019 Viral Clearance Symposium, Session 5: Viral Inactivation
Junfen Ma

PDA Journal of Pharmaceutical Science and Technology July 2022, 76 (4) 339-348; DOI: https://doi.org/10.5731/pdajpst.2021.012681
You have access
Proceedings of the 2019 Viral Clearance Symposium, Session 6: Virus-Retentive Filtration
Sean O’Donnell and Glen Bolton

PDA Journal of Pharmaceutical Science and Technology July 2022, 76 (4) 349-357; DOI: https://doi.org/10.5731/pdajpst.2021.012682
You have access
Proceedings of the 2019 Viral Clearance Symposium, Session 8. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments and Actions
Glen Bolton

PDA Journal of Pharmaceutical Science and Technology July 2022, 76 (4) 362-367; DOI: https://doi.org/10.5731/pdajpst.2021.012684
You have access
Twenty plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal
Brad Stanley, Veronica Holmes, Richard Manzari, Cara Romanowski, Anja Tessarz, Horst Ruppach and John Schreffler

PDA Journal of Pharmaceutical Science and Technology January 2022, 76 (1) 1-8; DOI: https://doi.org/10.5731/pdajpst.2020.012591
You have access
The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim
Dwaine Banton, Dominick Vacante, Ben Bulthuis, Josh Goldstein, Michael Wineburg and John Schreffler

PDA Journal of Pharmaceutical Science and Technology November 2019, 73 (6) 552-561; DOI: https://doi.org/10.5731/pdajpst.2019.010116
You have access
Retrospective Evaluation of Cycled Resin in Viral Clearance Studies—A Multiple Company Collaboration
John Mattila, Sherrie Curtis, Yenny Webb-Vargas, Eileen Wilson, Olga Galperina, David Roush, Scott Tobler, Bradford Stanley, Mike Clark, Justin Weaver, Jeremy Pike, Deqiang Yu, Xinfang Li, Andreas Flicker, Johanna Kindermann, Norbert Schuelke, Richard Whitcombe and Louise Bennett

PDA Journal of Pharmaceutical Science and Technology September 2019, 73 (5) 470-486; DOI: https://doi.org/10.5731/pdajpst.2018.009605
You have access
PDA Biosimilars Workshop Report (September 27—28, 2018)—Getting It Right the First Time for Biosimilar Marketing Applications
Stephan Krause, Emanuela Lacana, Joel Welch, Marjorie Shapiro, Christopher Downey, Jee Chung, Qing Zhou, Martijn Van Der Plas, Chantal Depatie, Bev Ingram, Catherine Srebalus-Barnes, Alla Polozova, Barbara Rellahan, Daeseok Choi, Richard Burdick, Thomas Stangler and Emily Shacter

PDA Journal of Pharmaceutical Science and Technology July 2019, 73 (4) 401-416; DOI: https://doi.org/10.5731/pdajpst.2019.010215
You have access
Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing
Paul W. Barone, Stephen Avgerinos, Rob Ballard, Audrey Brussel, Philip Clark, Chris Dowd, Lionel Gerentes, Ian Hart, Flora J. Keumurian, Johanna Kindermann, James C. Leung, Nguyen Ly, Sheldon Mink, Stefan Minning, Jürgen Mullberg, Marie Murphy, Kerstin Nöske, Sandi Parriott, Bonnie Shum, Michael E. Wiebe and Stacy L. Springs

PDA Journal of Pharmaceutical Science and Technology March 2019, 73 (2) 191-203; DOI: https://doi.org/10.5731/pdajpst.2018.008862
You have access
Proceedings of the 2017 Viral Clearance Symposium—
Stefan Hepbildikler and Franz Nothelfer

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 453-454; DOI: https://doi.org/10.5731/pdajpst.2018.009076
You have access
Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations–Purification Unit Operations
David Roush and Thomas R. Kreil

PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 479-487; DOI: https://doi.org/10.5731/pdajpst.2018.009126

Main menu

User menu

Search

Viral clearance

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.